LRRC15 is a type I transmembrane protein overexpressed in cancer-associated fibroblasts (CAFs) and mesenchymal tumors. Antibodies targeting LRRC15, such as ABBV-085, are engineered to deliver cytotoxic payloads to the tumor microenvironment (TME) while sparing normal tissues .
Domains: Extracellular leucine-rich repeats (LRRs), a transmembrane domain, and a short cytoplasmic tail .
Expression: Induced by TGFβ in activated fibroblasts (αSMA+) and mesenchymal stem cells .
ABBV-085: A humanized IgG1 antibody conjugated to monomethyl auristatin E (MMAE) via a cleavable valine-citrulline linker. Drug-to-antibody ratio (DAR) ≈ 2 .
Mechanism: Binds LRRC15 on CAFs or cancer cells, internalizes, releases MMAE to induce apoptosis, and facilitates bystander killing via cell-permeable payloads .
LRRC15 is highly expressed in stromal fibroblasts across multiple cancers but absent in most normal tissues :
| Tumor Type | Prevalence (LRRC15 ≥2+ IHC Score) | Key Observations |
|---|---|---|
| Breast Cancer | 95% (72/76) | Stromal expression in triple-negative subtypes |
| Head and Neck | 81% (182/226) | Matched primary/metastasis expression |
| Pancreatic Cancer | 66% (27/41) | Co-localization with αSMA+ CAFs |
| Sarcoma | 72% (28/39) | Direct cancer cell expression |
| Glioblastoma (GBM) | 23% (7/31) | Mixed stromal/cancer cell expression |
Monotherapy: ABBV-085 reduced tumor growth in LRRC15+ xenograft models (e.g., U118MG glioblastoma, Hs729 sarcoma) .
Combination Therapy: Enhanced efficacy with standard chemotherapies (e.g., gemcitabine in pancreatic cancer) .
Immune Modulation: Increased tumor-infiltrating macrophages (F4/80+) and reduced immunosuppressive cytokines .
Stromal Targeting: Spares normal tissues due to LRRC15’s restricted expression (hair follicles, osteoblasts, wound sites) .
Payload Delivery: MMAE’s bystander effect kills adjacent cancer cells despite heterogeneous LRRC15 expression .
Dosing: Sustained plasma persistence allows less frequent administration .
Phase I Trials: ABBV-085 is under evaluation for safety and preliminary efficacy in LRRC15+ solid tumors .
Biomarker Strategy: LRRC15 IHC scoring (≥2+ in ≥25% stromal/cancer cells) guides patient selection .
KEGG: ath:AT2G05335
STRING: 3702.AT2G05335.1
SCRL15 Antibody (product code CSB-PA306552XA01DOA) is a polyclonal antibody raised against the SCRL15 protein specifically from Arabidopsis thaliana (Mouse-ear cress), a widely used model organism in plant molecular biology. This antibody recognizes the SCRL15 protein corresponding to UniProt accession number P82634 and is produced by immunizing rabbits with recombinant Arabidopsis thaliana SCRL15 protein. The antibody has been affinity-purified to enhance its specificity for the target antigen .
Unlike SCRN1 antibodies which target human secernin family proteins , SCRL15 Antibody is specifically designed for plant research applications, primarily targeting Arabidopsis systems. Understanding this fundamental distinction is crucial as researchers might confuse these similarly named but functionally and taxonomically distinct antibodies.
SCRL15 Antibody should be stored at either -20°C or -80°C upon receipt. Repeated freeze-thaw cycles should be strictly avoided as they can significantly compromise antibody functionality. The antibody is supplied in a liquid formulation containing a preservative (0.03% Proclin 300) and stabilizers (50% Glycerol, 0.01M PBS, pH 7.4) that help maintain its activity during storage .
SCRL15 Antibody has been validated for use in Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB) applications . These techniques are fundamental for detecting and quantifying proteins in complex biological samples from Arabidopsis thaliana.
When designing experiments, researchers should consider the following application-specific recommendations:
| Application | Recommended Dilution | Sample Preparation | Detection Method |
|---|---|---|---|
| Western Blot | 1:500-1:2000* | Denatured protein lysates | Secondary antibody with HRP/AP conjugation |
| ELISA | 1:1000-1:5000* | Native protein samples | Enzyme-linked secondary detection |
*Note: Exact dilutions should be empirically determined for each experimental setup
For Western blotting applications, researchers may need to optimize various conditions including blocking reagents, incubation times, and detection methods to achieve optimal results.
Validating antibody specificity is a critical step that should be performed before conducting extensive experiments. For SCRL15 Antibody, consider implementing the following validation approaches:
Positive and negative controls: Use wild-type Arabidopsis thaliana tissue as a positive control and SCRL15 knockout mutants (if available) as negative controls.
Blocking peptide assay: Pre-incubate the antibody with excess purified SCRL15 protein or immunizing peptide before immunodetection. Specific signals should be significantly reduced or eliminated.
Molecular weight verification: The detected band in Western blot should correspond to the predicted molecular weight of SCRL15 protein.
Multiple detection methods: Confirm findings using orthogonal techniques such as immunofluorescence and ELISA.
This validation approach is similar to strategies used for other research antibodies like Anti-SCRN1, which often undergo rigorous validation to ensure specific detection of their target proteins .
Proper experimental controls are essential for generating reliable and interpretable data. For SCRL15 Antibody experiments, incorporate the following controls:
Technical controls:
Primary antibody omission (to assess non-specific binding of secondary antibody)
Secondary antibody only (to assess background)
Isotype control (rabbit IgG at equivalent concentration)
Biological controls:
Wild-type Arabidopsis thaliana samples
SCRL15 knockout/knockdown plant lines (if available)
Protein extracts from non-target species (to assess cross-reactivity)
Recombinant SCRL15 protein (as positive control)
Methodology controls:
Loading controls (e.g., anti-actin or anti-tubulin antibodies)
Molecular weight markers
Similar control strategies are commonly employed when working with other research antibodies to distinguish specific from non-specific signals .
Western blotting with SCRL15 Antibody can be optimized through careful attention to several key parameters:
Protein extraction: Use plant-specific extraction buffers containing protease inhibitors. For Arabidopsis thaliana tissues, consider using buffers containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, and a protease inhibitor cocktail.
Gel percentage: Select an appropriate acrylamide percentage based on the molecular weight of SCRL15 protein.
Transfer conditions: Optimize transfer time and voltage based on protein size.
Blocking solution: Test different blocking agents (5% non-fat milk, 3-5% BSA) to determine which provides the best signal-to-noise ratio.
Antibody dilution: Start with a 1:1000 dilution and adjust as needed based on signal intensity.
Incubation conditions: Test both overnight incubation at 4°C and shorter incubations at room temperature.
Washing steps: Use TBS-T (Tris-buffered saline with 0.1% Tween-20) with multiple wash steps to reduce background.
Detection system: Compare chemiluminescence, fluorescence, and colorimetric detection methods to determine optimal sensitivity.
This systematic optimization approach mirrors strategies used for other research antibodies in challenging experimental contexts .
SCRL15 Antibody can be employed for immunohistochemistry (IHC) and immunofluorescence (IF) to determine the subcellular and tissue-specific localization of SCRL15 protein:
Tissue preparation: Fix Arabidopsis tissues with 4% paraformaldehyde, embed in appropriate media, and prepare thin sections.
Antigen retrieval: Test heat-induced or enzymatic antigen retrieval methods to expose epitopes potentially masked during fixation.
Antibody incubation: Apply SCRL15 Antibody (typically at 1:100-1:500 dilution) followed by fluorophore-conjugated secondary antibody.
Counterstaining: Use DAPI for nuclear staining and other organelle-specific markers as needed.
Confocal microscopy: Analyze samples using confocal microscopy for high-resolution imaging of protein localization.
Colocalization studies: Combine with other antibodies targeting known subcellular markers to determine precise localization.
This approach can generate valuable insights into protein function through spatial distribution analysis, similar to techniques used in other immunofluorescence applications with polyclonal antibodies .
When faced with contradictory or inconsistent results when using SCRL15 Antibody, consider implementing these troubleshooting strategies:
Antibody validation review: Re-validate antibody specificity using knockout controls and blocking peptides.
Sample preparation assessment: Evaluate whether different protein extraction or tissue fixation methods affect results.
Technical replication: Perform multiple technical and biological replicates to assess variability.
Alternative detection methods: Compare results across different detection platforms (e.g., chemiluminescence vs. fluorescence).
Antibody lot comparison: Test multiple lots of the antibody to identify potential lot-to-lot variations.
Cross-laboratory validation: If possible, have experiments performed in different laboratories to identify facility-specific variables.
Complementary approaches: Support antibody-based findings with complementary techniques such as RT-PCR, RNA-seq, or mass spectrometry.
Addressing contradictory results systematically is crucial for maintaining scientific rigor in antibody-based research, as demonstrated in studies of complex antibody-dependent processes .
SCRL15 Antibody can facilitate the study of protein-protein interactions through several advanced techniques:
These approaches can reveal functional protein networks, similar to techniques used in studying complex protein interactions in other biological systems .
Weak or absent signals when using SCRL15 Antibody could result from several factors. Consider the following potential causes and solutions:
| Problem | Possible Cause | Solution |
|---|---|---|
| Low expression of target protein | Developmental stage or tissue-specificity | Use tissues/conditions known to express SCRL15 |
| Inefficient protein extraction | Inappropriate buffer or method | Optimize extraction protocol for plant tissues |
| Antibody degradation | Improper storage or handling | Use fresh aliquots, avoid freeze-thaw cycles |
| Insufficient primary antibody | Too low concentration | Increase antibody concentration or incubation time |
| Inefficient blocking | High background masking signal | Optimize blocking reagent and duration |
| Inefficient detection system | Expired or degraded detection reagents | Use fresh detection reagents |
| Incompatible transfer conditions | Improper transfer for protein size | Adjust transfer conditions based on protein size |
| Epitope masking | Protein folding or post-translational modifications | Try different sample preparation methods |
This systematic troubleshooting approach is similar to methods used for optimizing experimental conditions in antibody applications across various research contexts .
High background and non-specific binding can significantly impact data quality and interpretation. Implement these strategies to improve signal specificity:
Blocking optimization:
Test different blocking agents (BSA, non-fat milk, normal serum, commercial blockers)
Extend blocking time (1-2 hours at room temperature or overnight at 4°C)
Antibody dilution adjustment:
Titrate antibody to find optimal concentration that maximizes specific signal while minimizing background
Consider using antibody dilution buffer with 0.1-0.5% detergent (Tween-20 or Triton X-100)
Washing protocol enhancement:
Increase number of washes (5-6 washes of 5-10 minutes each)
Use higher detergent concentration in wash buffer (0.1-0.3% Tween-20)
Pre-adsorption technique:
Pre-incubate antibody with tissues/extracts from non-target species
Remove non-specific antibodies through centrifugation before using for detection
Secondary antibody considerations:
Use highly cross-adsorbed secondary antibodies
Reduce secondary antibody concentration
These approaches have proven effective in improving signal-to-noise ratios in antibody-based detection systems across various experimental contexts .
Epitope masking can prevent antibody binding to its target, resulting in false-negative results. Consider these approaches to address potential epitope masking:
Antigen retrieval methods:
Heat-induced epitope retrieval (HIER): Heat samples in citrate buffer (pH 6.0) or Tris-EDTA buffer (pH 9.0)
Enzymatic epitope retrieval: Treat samples with proteolytic enzymes like proteinase K or trypsin
Alternative fixation protocols:
Test different fixatives (paraformaldehyde, glutaraldehyde, methanol)
Optimize fixation time and temperature
Denaturing conditions:
For Western blotting, ensure complete protein denaturation with reducing agents and adequate heating
Try different detergents in the sample buffer
Native protein detection:
If the epitope is conformational, consider native PAGE instead of SDS-PAGE
Use non-denaturing immunoprecipitation protocols
Alternative antibody:
If available, try antibodies targeting different epitopes of the same protein
Consider using a combination of antibodies for more robust detection
These methodological considerations are particularly important when working with plant proteins, which may have complex post-translational modifications or exist in protein complexes that can mask epitopes .
While not explicitly validated for ChIP applications, polyclonal antibodies like SCRL15 Antibody can potentially be adapted for chromatin immunoprecipitation studies if SCRL15 is involved in transcriptional regulation or chromatin interactions:
Protocol adaptation:
Optimize crosslinking conditions specifically for plant tissues (1-3% formaldehyde for 10-20 minutes)
Develop sonication parameters that efficiently fragment plant chromatin (typically 200-500 bp fragments)
Use higher antibody concentrations than typical IP (4-10 μg per reaction)
Controls and validation:
Include input controls (non-immunoprecipitated chromatin)
Perform mock IPs with pre-immune serum or IgG
Validate enrichment of known targets using qPCR before proceeding to sequencing
Data analysis considerations:
Compare enrichment patterns to transcriptomic data
Integrate with existing plant epigenomic datasets
Validate key findings with reporter gene assays
This application requires rigorous validation and optimization but can provide valuable insights into the potential role of SCRL15 in transcriptional regulation or chromatin organization .
When applying SCRL15 Antibody to study homologous proteins in plant species beyond Arabidopsis thaliana, researchers should consider:
Sequence homology assessment:
Perform sequence alignment of SCRL15 homologs across target species
Focus on epitope regions that might affect antibody recognition
Consider evolutionary distance between species
Cross-reactivity testing:
Perform Western blot validation using protein extracts from target species
Include Arabidopsis extracts as positive control
Verify molecular weight differences based on predicted protein sequences
Antibody concentration optimization:
Higher concentrations may be needed for distantly related species
Titrate antibody to determine optimal working dilution for each species
Alternative validation approaches:
Complement antibody-based detection with mass spectrometry
Consider generating species-specific antibodies for critical applications
Cross-species applications require careful validation to ensure specificity, similar to approaches used when applying antibodies across different mammalian species or experimental systems .